# A Study of Recombinant Human Albumin Injection to Treat Hypoalbuminemia in Cirrhotic Patients With Ascites

> **NCT06911554** · PHASE3 · COMPLETED · sponsor: **Tonghua Anrate Biopharmaceutical Co., Ltd.** · enrollment: 416 (actual)

## Conditions studied

- Hepatic Ascites

## Interventions

- **BIOLOGICAL:** Recombinant Human Albumin Injection
- **BIOLOGICAL:** Human Albumin

## Key facts

- **NCT ID:** NCT06911554
- **Lead sponsor:** Tonghua Anrate Biopharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-06-16
- **Primary completion:** 2024-09-27
- **Final completion:** 2024-09-27
- **Target enrollment:** 416 (ACTUAL)
- **Last updated:** 2025-04-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06911554

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06911554, "A Study of Recombinant Human Albumin Injection to Treat Hypoalbuminemia in Cirrhotic Patients With Ascites". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT06911554. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*